115
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Serpiginous Choroiditis with Atypical Presentation Treated with Intravenous Methyl Prednisolone

, , , &
Pages 157-159 | Received 10 Feb 2013, Accepted 09 Aug 2013, Published online: 11 Oct 2013

References

  • Lim W-K, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Sur Ophthalmol 2005;50:231–244
  • Markomichelakis NN, Halkiadakis I, Papaeythymiou-Orchan S, et al. Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis. Ocul Immunol Inflamm 2006;14:29–23
  • Gupta V, Gupta A, Arora S, et al. Presumed tubercular serpiginous like choroiditis: Clinical presentations and management. Ophthalmology 2003;110 (9):1744–1749
  • Zacks DN, D’Amico DJ. Maculopathies that resemble optic neuropathies. Int Ophthalmol Clin 2001 winter;41(1):61–71
  • Sonika, Narang S, Kocchar S, et al. Posterior scleritis mimicking macular serpiginous choroiditis. Indian J Opthalmol 2003; 51(4):351–353
  • Laatikainen L, Erkkila H. Serpiginous choroiditis. Br J Ophthalmol 1974;58:777–783
  • Hoyng C, Tilanus M, Deutman A. Atypical central lesions in serpiginous choroiditis treated with oral prednisone. Graefes Arch Clin Exp Ophthalmol 1998;236:154–164
  • Vianna RN, Ozdal PC, Deschênes J, et al. Combination of azathioprine and corticosteroids in the treatment of serpiginous choroiditis. Can J Ophthalmol 2006;41(2):183–189

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.